Profiling mRNA in FFPE with the HTG EdgeSeq Oncology Biomarker Panel

Message RNA (mRNA) conveys genetic information from DNA to the ribosome for protein synthesis.  While every cell contains an entire genome, every tissue type has a unique expression profile. Tumor tissues exhibit abnormal profiles when compared to their normal counterparts, and tumor profiling can further elucidate the characteristics of a particular cancer.


Analysis of Common Breast Oncology Biomarkers 


The example above illustrates the use of a quantitative nuclease protection assay (qNPA) to effectively characterize and differentiate tumor types. Samples A, C, F and J are clearly HER-2 positive while samples B, E, G, and I are ESR1/PGR positive. Samples D and H are “triple negative” for ESR1, PGR and HER2; however, they are upregulated in EGFR as highlighted in the subchart.

HTG is currently developing the HTG EdgeSeq Oncology Biomarker Panel, which will enable profiling 2,560 oncology biomarkers. This product is expected to have wide utility across multiple tumor types, and can potentially enable discovery of unique tumor profiles.

Learn more about HTG EdgeSeq products and chemistry


HTG EdgeSeq Workflow and HTG EdgeSeq Chemistry


Evaluation of normalization methods for miRNA sequencing data generated with qNPA

Ordering Information

Catalog # Description
916-002-208 HTG EdgeSeq Oncology Biomarker Panel (2x8)
916-002-008 HTG EdgeSeq Oncology Biomarker Panel (4x8)
916-002-224 HTG EdgeSeq Oncology Biomarker Panel (1x24)
916-002-024 HTG EdgeSeq Oncology Biomarker Panel (4x24)
916-002-096 HTG EdgeSeq Oncology Biomarker Panel (1x96)
Ion Torrent 
916-002-308 HTG EdgeSeq Oncology Biomarker Panel (2x8)
916-002-108 HTG EdgeSeq Oncology Biomarker Panel (4x8)
916-002-324 HTG EdgeSeq Oncology Biomarker Panel (1x24)
916-002-124 HTG EdgeSeq Oncology Biomarker Panel (4x24)


For Research Use Only. Not for use in diagnostic procedures.

Website Section: 

Last updated: 12/28/2016 - 13:05